March 12, 2020

BioLineRx Reports Year-End 2019 Financial Results and Provides Corporate Update

March 6, 2020

BioLineRx to Report Annual 2019 Results on March 12, 2020

February 27, 2020

BioLineRx Announces Notice of Allowance from USPTO for Patent Covering Motixafortide (BL-8040) in Combination With Anti-PD-1 for the Treatment of Any Type of Cancer